Annual CFO
$30.92 M
+$6.06 M+24.37%
31 December 2023
Summary:
Organogenesis Holdings annual cash flow from operations is currently $30.92 million, with the most recent change of +$6.06 million (+24.37%) on 31 December 2023. During the last 3 years, it has risen by +$25.45 million (+465.62%). ORGO annual CFO is now -50.12% below its all-time high of $61.98 million, reached on 31 December 2021.ORGO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$8.70 M
+$3.96 M+83.52%
30 September 2024
Summary:
Organogenesis Holdings quarterly cash flow from operations is currently $8.70 million, with the most recent change of +$3.96 million (+83.52%) on 30 September 2024. Over the past year, it has dropped by -$8.04 million (-48.04%). ORGO quarterly CFO is now -68.78% below its all-time high of $27.85 million, reached on 30 September 2021.ORGO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$13.88 M
-$8.04 M-36.67%
30 September 2024
Summary:
Organogenesis Holdings TTM cash flow from operations is currently $13.88 million, with the most recent change of -$8.04 million (-36.67%) on 30 September 2024. Over the past year, it has dropped by -$14.22 million (-50.59%). ORGO TTM CFO is now -79.35% below its all-time high of $67.25 million, reached on 30 September 2021.ORGO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.4% | -48.0% | -50.6% |
| 3 y3 years | +465.6% | -68.8% | -79.3% |
| 5 y5 years | +151.0% | +259.4% | +131.2% |
ORGO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -50.1% | +465.6% | -68.8% | +185.6% | -79.3% | at low |
| 5 y | 5 years | -50.1% | +151.0% | -68.8% | +150.3% | -79.3% | +131.2% |
| alltime | all time | -50.1% | +151.0% | -68.8% | +137.8% | -79.3% | +121.1% |
Organogenesis Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.70 M(+83.5%) | $13.88 M(-36.7%) |
| June 2024 | - | $4.74 M(-146.6%) | $21.92 M(-15.1%) |
| Mar 2024 | - | -$10.16 M(-195.7%) | $25.83 M(-16.4%) |
| Dec 2023 | $30.92 M(+24.4%) | $10.61 M(-36.6%) | $30.92 M(+10.0%) |
| Sept 2023 | - | $16.73 M(+93.5%) | $28.10 M(+67.1%) |
| June 2023 | - | $8.65 M(-270.3%) | $16.82 M(-8.4%) |
| Mar 2023 | - | -$5.08 M(-165.1%) | $18.37 M(-26.1%) |
| Dec 2022 | $24.86 M(-59.9%) | $7.80 M(+43.0%) | $24.86 M(-29.0%) |
| Sept 2022 | - | $5.45 M(-46.5%) | $35.01 M(-39.0%) |
| June 2022 | - | $10.20 M(+622.5%) | $57.40 M(-11.3%) |
| Mar 2022 | - | $1.41 M(-92.1%) | $64.69 M(+4.4%) |
| Dec 2021 | $61.98 M(+1033.9%) | $17.95 M(-35.6%) | $61.98 M(-7.8%) |
| Sept 2021 | - | $27.85 M(+59.3%) | $67.25 M(+39.3%) |
| June 2021 | - | $17.48 M(-1444.6%) | $48.26 M(+125.0%) |
| Mar 2021 | - | -$1.30 M(-105.6%) | $21.45 M(+292.4%) |
| Dec 2020 | $5.47 M | $23.21 M(+161.8%) | $5.47 M(-122.6%) |
| Sept 2020 | - | $8.87 M(-195.0%) | -$24.15 M(-37.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$9.34 M(-46.0%) | -$38.47 M(-6.7%) |
| Mar 2020 | - | -$17.28 M(+170.0%) | -$41.25 M(+23.0%) |
| Dec 2019 | -$33.53 M(-44.7%) | -$6.40 M(+17.4%) | -$33.53 M(-24.7%) |
| Sept 2019 | - | -$5.45 M(-55.0%) | -$44.53 M(-28.3%) |
| June 2019 | - | -$12.12 M(+26.8%) | -$62.07 M(-5.6%) |
| Mar 2019 | - | -$9.56 M(-45.1%) | -$65.74 M(+8.4%) |
| Dec 2018 | -$60.63 M(+1635.9%) | -$17.41 M(-24.3%) | -$60.63 M(+31.2%) |
| Sept 2018 | - | -$22.99 M(+45.7%) | -$46.23 M(+97.5%) |
| June 2018 | - | -$15.78 M(+254.1%) | -$23.40 M(+199.2%) |
| Mar 2018 | - | -$4.46 M(+48.7%) | -$7.82 M(+124.0%) |
| Dec 2017 | -$3.49 M(-28.3%) | -$3.00 M(+1677.2%) | -$3.49 M(-34.6%) |
| Sept 2017 | - | -$168.70 K(-15.5%) | -$5.34 M(+2.8%) |
| June 2017 | - | -$199.70 K(+58.1%) | -$5.20 M(+4.0%) |
| Mar 2017 | - | -$126.30 K(-97.4%) | -$5.00 M(+2.6%) |
| Dec 2016 | -$4.87 M | -$4.85 M(>+9900.0%) | -$4.87 M(>+9900.0%) |
| Sept 2016 | - | -$24.50 K(<-9900.0%) | -$24.50 K(<-9900.0%) |
| June 2016 | - | $200.00(-200.0%) | $0.00(-100.0%) |
| Mar 2016 | - | -$200.00 | -$200.00 |
FAQ
- What is Organogenesis Holdings annual cash flow from operations?
- What is the all time high annual CFO for Organogenesis Holdings?
- What is Organogenesis Holdings annual CFO year-on-year change?
- What is Organogenesis Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly CFO year-on-year change?
- What is Organogenesis Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Organogenesis Holdings?
- What is Organogenesis Holdings TTM CFO year-on-year change?
What is Organogenesis Holdings annual cash flow from operations?
The current annual CFO of ORGO is $30.92 M
What is the all time high annual CFO for Organogenesis Holdings?
Organogenesis Holdings all-time high annual cash flow from operations is $61.98 M
What is Organogenesis Holdings annual CFO year-on-year change?
Over the past year, ORGO annual cash flow from operations has changed by +$6.06 M (+24.37%)
What is Organogenesis Holdings quarterly cash flow from operations?
The current quarterly CFO of ORGO is $8.70 M
What is the all time high quarterly CFO for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly cash flow from operations is $27.85 M
What is Organogenesis Holdings quarterly CFO year-on-year change?
Over the past year, ORGO quarterly cash flow from operations has changed by -$8.04 M (-48.04%)
What is Organogenesis Holdings TTM cash flow from operations?
The current TTM CFO of ORGO is $13.88 M
What is the all time high TTM CFO for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM cash flow from operations is $67.25 M
What is Organogenesis Holdings TTM CFO year-on-year change?
Over the past year, ORGO TTM cash flow from operations has changed by -$14.22 M (-50.59%)